KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $63,258,000 | +426.1% | 351,807 | +203.3% | 0.06% | +441.7% |
| Q2 2017 | $12,024,000 | -35.8% | 115,974 | -51.4% | 0.01% | -40.0% |
| Q1 2017 | $18,728,000 | +1960.3% | 238,605 | +1077.0% | 0.02% | +1900.0% |
| Q4 2016 | $909,000 | -94.1% | 20,273 | -92.6% | 0.00% | -93.8% |
| Q3 2016 | $15,284,000 | +9452.5% | 273,631 | +7579.8% | 0.02% | – |
| Q1 2016 | $160,000 | -5.3% | 3,563 | +28.5% | 0.00% | – |
| Q4 2015 | $169,000 | -66.7% | 2,773 | -70.0% | 0.00% | – |
| Q3 2015 | $508,000 | +1236.8% | 9,238 | +1361.7% | 0.00% | – |
| Q2 2015 | $38,000 | -98.1% | 632 | -98.2% | 0.00% | -100.0% |
| Q1 2015 | $2,042,000 | +3984.0% | 35,821 | +4041.2% | 0.00% | – |
| Q4 2014 | $50,000 | – | 865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |